Fieldview Capital Management, LLC Bristol Myers Squibb CO Transaction History
Fieldview Capital Management, LLC
- $612 Billion
- Q3 2025
A detailed history of Fieldview Capital Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Fieldview Capital Management, LLC holds 58,695 shares of BMY stock, worth $2.75 Million. This represents 0.43% of its overall portfolio holdings.
Number of Shares
58,695
Previous 12,348
375.34%
Holding current value
$2.75 Million
Previous $572 Million
363.12%
% of portfolio
0.43%
Previous 0.09%
Shares
4 transactions
Others Institutions Holding BMY
# of Institutions
2,684Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...